Document is current

Article History

Received: 8 January 2023

Accepted: 18 July 2023

First Online: 26 September 2023

Declarations

: Ethical approval and consent to participateThis study obtained ethical approval (IR.IUMS.REC.1400.753) on 21 November 2021 from the Ethics Committee of the Iran University of Medical Sciences. The first author (MM) will obtain informed consent from all individuals prior to any procedures. Study participants will be able to withdraw from participating at any time. Participants will be asked on the consent form if they approve of the usage of their data in the event that they choose to withdraw from the study. Participants will also be requested for their consent to allow the research team to share pertinent data with individuals from the university. We will not collect biological specimens in this trial.The trial results will be published in scientific journals and presented at neurology or occupational therapy conferences. Participants will be able to receive information about the trial’s findings.Patient/Public Involvement:Since there has been a paradigm shift towards the active involvement of patients in research design in recent years, we have included patients’ opinions regarding the level of responsibility in occupations and determining the responsibility feedback statements and occupational therapy priorities.Adverse event reporting and harms:No physical or psychological harm was anticipated in this trial, although the Iran University of Medical Sciences Ethics committee will be informed of any potential issues, whether physical or mental, that emerge as a result of the treatment. As per the Ethics Committee’s rules, the study team will give precedence to unpaid evaluation and treatment. Given the predicted low risk of harm from a participant’s involvement in this research, there are no provisions for post-trial care.

: Not applicable

: The authors declare that they have no competing interests.